Back

The impact of APOC3 and APOE gene polymorphisms on response to statin therapy in acute myocardial infarction.

31 August 2019 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 1 - Acute coronary syndromes, coronary artery disease: treatment Pharmacotherapy ESC Premium Access ESC Congress 2019

About the speaker

Photo
Doctor Marina Teterina

PFUR, Vilnius (Lithuania)

16 More presentations in this session

Presentation thumbnail
Incidence of coronary heart disease in patients with familiar hypercholesterolemia compared to age- and sex- matched controls
Doctor K. Svendsen (Oslo, NO)
Abstract Slides
Presentation thumbnail
Post-procedural cholesterol and inflammatory risk in acute myocardial infarction patients undergoing percutaneous coronary intervention
Doctor R. CHEN (Beijing, CN)
Abstract Slides
Presentation thumbnail
The prevalence and management of familial hypercholesterolemia in patients with acute coronary syndrome in Poland: results of the TERCET Registry
Associate Professor K. Dyrbus (Zabrze, PL)
Abstract Slides
Presentation thumbnail
Treatment patterns of lipid lowering therapy in patients with coronary artery disease above vs. below 75 years of age
Doctor A. Mahabadi (Essen, DE)
Abstract
Presentation thumbnail
Statin treatment in symptomatic patients with non-obstructive coronary artery disease reduces the risk of all-cause mortality
Doctor C. Kissel (Zurich, CH)
Abstract Slides

Access the full session

Session thumbnail
Poster Session 1 - Acute coronary syndromes, coronary artery disease: treatment

The Event

Event poster

ESC Congress 2019

31 August - 4 September 2019

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources